In this paper, Deep Neural Networks (DNN) with Bat Algorithms (BA) offer a dynamic form of traffic control in Vehicular Adhoc Networks (VANETs). The former is used to route vehicles across highly congested paths to enhance efficiency, with a lower average latency. The latter is combined with the Internet of Things (IoT) and it moves across the VANETs to analyze the traffic congestion status between the network nodes. The experimental analysis tests the effectiveness of DNN-IoT-BA in various machine or deep learning algorithms in VANETs. DNN-IoT-BA is validated through various network metrics, like packet delivery ratio, latency and packet error rate. The simulation results show that the proposed method provides lower energy consumption and latency than conventional methods to support real-time traffic conditions.

In recent time, data analysis using machine learning accelerates optimized solutions on clinical healthcare systems. The machine learning methods greatly offer an efficient prediction ability in diagnosis system alternative with the clinicians. Most of the systems operate on the extracted features from the patients and most of the predicted cases are accurate. However, in recent time, the prevalence of COVID-19 has emerged the global healthcare industry to find a new drug that suppresses the pandemic outbreak. In this paper, we design a Deep Neural Network (DNN) model that accurately finds the protein-ligand interactions with the drug used. The DNN senses the response of protein-ligand interactions for a specific drug and identifies which drug makes the interaction that combats effectively the virus. With limited genome sequence of Indian patients submitted to the GISAID database, we find that the DNN system is effective in identifying the protein-ligand interactions for a specific drug.